Question 46

Rocuronium is considered a high-alert medication because it is a neuromuscular blocking agent.

Rocuronium is a neuromuscular blocking agent that is classified as a high-alert medication due to its potential to cause significant harm if used incorrectly. This classification emphasizes the need for careful handling and monitoring during its administration.

A) Rocuronium

Rocuronium is indeed a neuromuscular blocking agent used during surgical procedures to facilitate intubation and provide muscle relaxation. It is classified as a high-alert medication because errors in its use can lead to severe respiratory complications, making it critical for healthcare providers to exercise caution when administering it.

B) Rizatriptan

Rizatriptan is a medication used primarily to treat migraine headaches and does not function as a neuromuscular blocking agent. Therefore, it does not qualify as a high-alert medication in the context of neuromuscular blockade and is not associated with the same risks as Rocuronium.

C) Risperidone

Risperidone is an antipsychotic medication used to treat mental health disorders, such as schizophrenia and bipolar disorder. It is not a neuromuscular blocking agent and does not carry the same high-alert designation as Rocuronium, which is specifically related to its use in anesthesia and surgery.

D) Rosuvastatin

Rosuvastatin is a cholesterol-lowering medication that belongs to the statin class. It has no role as a neuromuscular blocking agent and is not categorized as a high-alert medication for the same reasons as Rocuronium, which is directly involved in muscle paralysis during surgical procedures.

Conclusion

Rocuronium stands out as the correct answer because it is specifically a neuromuscular blocking agent, necessitating heightened caution in its administration due to the risks involved. In contrast, the other options do not relate to neuromuscular blockade and thus do not meet the criteria for high-alert medications in this context.